Examkin

Question

Difficulty: MediumDiagnostic Testing Performance

A regional health authority has been operating a specialized screening program for *Trypanosoma cruzi* (Chagas disease) using a rapid point-of-care serological test. This program targets recent immigrants from highly endemic regions, a cohort in which the prevalence of the infection is estimated to be 18%. In this specific clinical setting, the serological test has demonstrated a sensitivity of 94% and a specificity of 97%.

Recently, the health authority expanded its screening efforts by deploying the exact same rapid test at a series of primary care clinics across a non-endemic, suburban district. In this new screening cohort, the prevalence of *Trypanosoma cruzi* is less than 0.05%.

When comparing the statistical performance of the rapid serological test in the new suburban district to its performance in the original specialized program, which of the following changes is expected?

  1. The positive predictive value will be lower, but the sensitivity and specificity will remain constant.Answer
  2. B
    The positive predictive value will be higher, but the sensitivity and specificity will remain constant.
  3. C
    The negative predictive value will be lower, but the sensitivity and specificity will remain constant.
  4. D
    The sensitivity will be lower, but the positive and negative predictive values will remain constant.
  5. E
    The specificity will be higher, but the positive and negative predictive values will remain constant.

Answer

The positive predictive value will be lower, but the sensitivity and specificity will remain constant.
Sensitivity and specificity are intrinsic performance characteristics of a diagnostic assay; they are independent of the population's disease prevalence. Therefore, deploying the test in a new population will not alter these values. However, predictive values depend heavily on prevalence. When a test is applied to a population with a drastically lower prevalence of the target disease, the number of true positive results drops significantly. Concurrently, the number of false positive results (driven by the constant false-positive rate applied to a much larger pool of healthy individuals) becomes disproportionately large. This mathematically dilutes the true positives among all positive results, resulting in a substantially lower positive predictive value.

Step-by-Step Solution

1
Identify the changing epidemiological variable.
The disease prevalence drops significantly from 18% in the endemic cohort to less than 0.05% in the suburban cohort.
Recognizing the change in the population baseline risk is required to determine the impact on statistical parameters.
2
Evaluate the impact on intrinsic test characteristics.
Sensitivity and specificity remain unaffected.
Sensitivity and specificity are inherent properties of the diagnostic assay and do not fluctuate with disease prevalence.
3
Evaluate the impact on predictive values.
The positive predictive value decreases.
As prevalence drops, the total number of true positive cases decreases drastically. Meanwhile, the constant false-positive rate is applied to a much larger pool of healthy individuals, resulting in a high number of false positives that dilute the true positives.

Key Concept

The effect of disease prevalence on diagnostic predictive values
Rate this question

Topics

Diagnostic Testing Performance

More questions from this topic